CGHAC Publications
| Guyda HJ, Friesen
HG, Bailey JD, et al. Medical Research Council of Canada
therapeutic trial of growth hormone: first five years of
therapy. Can Med Assoc J 1975;112:1301-1309 |
| Dean HJ, McTaggart
TL, Fish DG, Friesen HG. Evaluation of the educational,
vocational, and marital status of growth
hormone-deficient(GHD) adults treated with growth hormone
during childhood. Am J Dis Child,
1985;139:1105-1110. |
| Dean HJ, Friesen HG.
Growth hormone therapy in Canada: end of one era and
beginning of another. CMAJ 1986;135:297-301. |
| Dean HJ, Friesen HG,
and the members of the Therapeutic Trial of Growth
Hormone Committee, Medical Research Council of Canada.
Long-term growth of children with growth hormone
deficiency and hypoglycemia. J Pediatr
1989;115:598-600. |
| Holland J, Brnjac L,
Alexander D, et al. Turner syndrome and final adult
stature: a randomized controlled trial using human GH and
low dose ethinyl estradiol. In: Ranke MB, Rosenfeld RG,
eds. Turner Syndrome: Growth promoting therapies. Amsterdam:
Elsevier Science Publishers B.V., 1991:195-200. |
| Stephure DK, Holland
FJ, Alexander D, et al. Human growth hormone and low dose
ethinyl estradiol treatment in Turner syndrome: a
prospective randomized controlled trial to final height.
In: Hibi I, Takano K, eds. Basic and clinical approach to
Turner syndrome. Amsterdam: Elsevier Science
Publishers B.V., 1993:287-291. |
| Taback SP and Van
Vliet G, on behalf of the Canadian Growth Hormone
Advisory Committee. Growth hormone, adult height, and
psychosocial outcome in Turner syndrome: the need for
controlled studies. In: Albertsson-Wikland K, Ranke M,
eds. Turner Syndrome in a Life Span Perspective. Amsterdam:
Elsevier Science B.V., 1995:183-190. |
| Taback SP, Dean HJ
and members of the Canadian Growth Hormone Advisory
Committee, Mortality in Canada Children with Growth
Hormone (GH) Deficiency Receiving GH Therapy 1967-1992, J.Clin.Endocrinol.Metab.,
1996, 81:1693-1696. |